InflaRx NV buy Guggenheim
Start price
05.04.23
/
50%
€4.97
Target price
05.04.24
€7.32
Performance (%)
-71.61%
End price
06.04.24
€1.41
Summary
This prediction ended on 06.04.24 with a price of €1.41. Massive losses of -71.61% were the result for the BUY prediction by Guggenheim. Guggenheim has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
InflaRx NV | -9.469% | -9.469% | -63.338% |
iShares Core DAX® | -1.611% | 3.135% | 15.880% |
iShares Nasdaq 100 | -0.500% | 0.775% | 20.054% |
iShares Nikkei 225® | -1.483% | 4.610% | 11.154% |
iShares S&P 500 | -0.501% | 1.914% | 21.016% |
Comments by Guggenheim for this prediction
In the thread InflaRx NV diskutieren
InflaRx (NASDAQ: IFRX) was upgraded by analysts at Guggenheim from a "neutral" rating to a "buy" rating. They now have a $8.00 price target on the stock.
Ratings data for IFRX provided by MarketBeat
In the thread Trading InflaRx NV
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten